학술논문

Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial
Document Type
Article
Author
Anderson, AnnaAng, MaryBarnes, TimothyBassin, MichelleBessey, KateBowler, SimonBull, SheetalBurr, LucyBurton, RobertByrne, MichelleCarroll, RobertChee, NicholasChoy, AaronClark, MalcolmDalebout, MarijeDe Wet, PeterDeshmukh, KshamaDiez Alvarez, SergioDouglas, DominicEngelander, JacquelineEvangelista, CarlaGame, StuartGlass, NoorGunner, ElizabethHan, JenniferHarrison, MichaelHing Kiang, Jason DoongHlaing, ThazinJoshi, DivyanshJoyce, ShereeKaluhin, KarenKavic, MilankaKononov, JulianaLee, GaryLee, Wei-ILeelasena, IndikaLeong, EsmondLim, IvanLister, GrahamLoh, DenissaMagdy, MaryMaggs, CallumMammoottil, AmithMcCarthy, ShannonMcKay, NicoleMelek, MariahMichael Barnett, AdrianMohan, RahulMoore, AndrewMoore, AmandaMurdoch, LouiseNapier-Flood, FionaNarsai, UshmaNeville, AlexanderNguyen, PaulOdarchenko, EkaterinaPardey, ToniQuan, DickRanagsinghe, UshankRasalam, RoyRayar, ShivaRuthnam, Gonasagaran JaySeet, PiSmith, DeonSrilakshmanan, KrishnaTaggart, AngelaTiong, FlorenceToh, BoonUjvary, EnikoWallace, StephanieWolf, RebeccaWong, IanYoo, HyeYoung, RhysBennett, ChijiokeWoo, WayneBloch, MarkCheung, KingGriffin, PaulDeshmukh, SachinArya, MarkCumming, OscarNeville, A MunroMcCallum Pardey, Toni GPlested, Joyce SCloney-Clark, ShaneZhu, MingzhuKalkeri, RajPatel, NitaMarcheschi, AlexSwan, JenniferSmith, GaleCho, IksungGlenn, Gregory MWalker, RobertMallory, Raburn M
Source
In The Lancet Infectious Diseases
Subject
Primary Research
Articles
Language
ISSN
1473-3099